| Dr Angela Maryann Pansera, DO | |
|
7801 Old Branch Ave, Ste 300, Clinton, MD 20735-1608 | |
| (301) 856-6718 | |
| (301) 856-6722 |
| Full Name | Dr Angela Maryann Pansera |
|---|---|
| Gender | Female |
| Speciality | Diagnostic Radiology |
| Experience | 21 Years |
| Location | 7801 Old Branch Ave, Clinton, Maryland |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568613909 | NPI | - | NPPES |
| 1568613909 | Medicaid | VA | |
| 447817700 | Medicaid | MD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | C2-0008725 (Delaware) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Maryland Imaging Network Pc | 6103259304 | 43 |
News Archive
Patients with no schooling benefit least from blood thinning medications, reveals a European Heart Rhythm Association / European Society of Cardiology survey published today in Europace.
An open-source platform, OpenEP co-developed by researchers from the School of Biomedical Engineering & Imaging Sciences at King's College London has been made available to advance research on atrial fibrillation, a condition characterized by an irregular and often fast heartbeat.
"Although coming off a rocky year in 2011, the Global Fund to Fight AIDS, Tuberculosis and Malaria is 'not in crisis,'" Inter Press Service reports, referring to comments made by the organization's deputy general manager, Debrework Zewdie, at a roundtable hosted by the Council on Foreign Relations on Wednesday. Zewdie noted the resumption of commitments to the fund from bilateral donors, despite the international economic crisis and last year's allegations of mismanagement, the news service adds.
Soligenix, Inc., a late-stage biopharmaceutical company, today announced that it has entered into a definitive license agreement with the University of Colorado (CU) for novel technology for use in the development of subunit vaccines with long-term stability, including stability at elevated temperatures.
Inovio Pharmaceuticals, Inc. today reported financial results for the quarter ended June 30, 2014. Total revenue was $3.8 million and $6.2 million for the three and six months ended June 30, 2014, compared to $786,000 and $2.2 million for the same periods in 2013.
› Verified 1 days ago
| Entity Name | American Radiology Associates,p.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780660217 PECOS PAC ID: 6406750520 Enrollment ID: O20031120000944 |
News Archive
Patients with no schooling benefit least from blood thinning medications, reveals a European Heart Rhythm Association / European Society of Cardiology survey published today in Europace.
An open-source platform, OpenEP co-developed by researchers from the School of Biomedical Engineering & Imaging Sciences at King's College London has been made available to advance research on atrial fibrillation, a condition characterized by an irregular and often fast heartbeat.
"Although coming off a rocky year in 2011, the Global Fund to Fight AIDS, Tuberculosis and Malaria is 'not in crisis,'" Inter Press Service reports, referring to comments made by the organization's deputy general manager, Debrework Zewdie, at a roundtable hosted by the Council on Foreign Relations on Wednesday. Zewdie noted the resumption of commitments to the fund from bilateral donors, despite the international economic crisis and last year's allegations of mismanagement, the news service adds.
Soligenix, Inc., a late-stage biopharmaceutical company, today announced that it has entered into a definitive license agreement with the University of Colorado (CU) for novel technology for use in the development of subunit vaccines with long-term stability, including stability at elevated temperatures.
Inovio Pharmaceuticals, Inc. today reported financial results for the quarter ended June 30, 2014. Total revenue was $3.8 million and $6.2 million for the three and six months ended June 30, 2014, compared to $786,000 and $2.2 million for the same periods in 2013.
› Verified 1 days ago
| Entity Name | Community Radiology Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396707782 PECOS PAC ID: 5991692444 Enrollment ID: O20041014000909 |
News Archive
Patients with no schooling benefit least from blood thinning medications, reveals a European Heart Rhythm Association / European Society of Cardiology survey published today in Europace.
An open-source platform, OpenEP co-developed by researchers from the School of Biomedical Engineering & Imaging Sciences at King's College London has been made available to advance research on atrial fibrillation, a condition characterized by an irregular and often fast heartbeat.
"Although coming off a rocky year in 2011, the Global Fund to Fight AIDS, Tuberculosis and Malaria is 'not in crisis,'" Inter Press Service reports, referring to comments made by the organization's deputy general manager, Debrework Zewdie, at a roundtable hosted by the Council on Foreign Relations on Wednesday. Zewdie noted the resumption of commitments to the fund from bilateral donors, despite the international economic crisis and last year's allegations of mismanagement, the news service adds.
Soligenix, Inc., a late-stage biopharmaceutical company, today announced that it has entered into a definitive license agreement with the University of Colorado (CU) for novel technology for use in the development of subunit vaccines with long-term stability, including stability at elevated temperatures.
Inovio Pharmaceuticals, Inc. today reported financial results for the quarter ended June 30, 2014. Total revenue was $3.8 million and $6.2 million for the three and six months ended June 30, 2014, compared to $786,000 and $2.2 million for the same periods in 2013.
› Verified 1 days ago
| Entity Name | Inova Health Care Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952320061 PECOS PAC ID: 2466351093 Enrollment ID: O20160209000188 |
News Archive
Patients with no schooling benefit least from blood thinning medications, reveals a European Heart Rhythm Association / European Society of Cardiology survey published today in Europace.
An open-source platform, OpenEP co-developed by researchers from the School of Biomedical Engineering & Imaging Sciences at King's College London has been made available to advance research on atrial fibrillation, a condition characterized by an irregular and often fast heartbeat.
"Although coming off a rocky year in 2011, the Global Fund to Fight AIDS, Tuberculosis and Malaria is 'not in crisis,'" Inter Press Service reports, referring to comments made by the organization's deputy general manager, Debrework Zewdie, at a roundtable hosted by the Council on Foreign Relations on Wednesday. Zewdie noted the resumption of commitments to the fund from bilateral donors, despite the international economic crisis and last year's allegations of mismanagement, the news service adds.
Soligenix, Inc., a late-stage biopharmaceutical company, today announced that it has entered into a definitive license agreement with the University of Colorado (CU) for novel technology for use in the development of subunit vaccines with long-term stability, including stability at elevated temperatures.
Inovio Pharmaceuticals, Inc. today reported financial results for the quarter ended June 30, 2014. Total revenue was $3.8 million and $6.2 million for the three and six months ended June 30, 2014, compared to $786,000 and $2.2 million for the same periods in 2013.
› Verified 1 days ago
| Entity Name | Maryland Imaging Network Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487296471 PECOS PAC ID: 6103259304 Enrollment ID: O20191202001049 |
News Archive
Patients with no schooling benefit least from blood thinning medications, reveals a European Heart Rhythm Association / European Society of Cardiology survey published today in Europace.
An open-source platform, OpenEP co-developed by researchers from the School of Biomedical Engineering & Imaging Sciences at King's College London has been made available to advance research on atrial fibrillation, a condition characterized by an irregular and often fast heartbeat.
"Although coming off a rocky year in 2011, the Global Fund to Fight AIDS, Tuberculosis and Malaria is 'not in crisis,'" Inter Press Service reports, referring to comments made by the organization's deputy general manager, Debrework Zewdie, at a roundtable hosted by the Council on Foreign Relations on Wednesday. Zewdie noted the resumption of commitments to the fund from bilateral donors, despite the international economic crisis and last year's allegations of mismanagement, the news service adds.
Soligenix, Inc., a late-stage biopharmaceutical company, today announced that it has entered into a definitive license agreement with the University of Colorado (CU) for novel technology for use in the development of subunit vaccines with long-term stability, including stability at elevated temperatures.
Inovio Pharmaceuticals, Inc. today reported financial results for the quarter ended June 30, 2014. Total revenue was $3.8 million and $6.2 million for the three and six months ended June 30, 2014, compared to $786,000 and $2.2 million for the same periods in 2013.
› Verified 1 days ago
| Entity Name | Ifrc Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508405317 PECOS PAC ID: 2961829882 Enrollment ID: O20200825002448 |
News Archive
Patients with no schooling benefit least from blood thinning medications, reveals a European Heart Rhythm Association / European Society of Cardiology survey published today in Europace.
An open-source platform, OpenEP co-developed by researchers from the School of Biomedical Engineering & Imaging Sciences at King's College London has been made available to advance research on atrial fibrillation, a condition characterized by an irregular and often fast heartbeat.
"Although coming off a rocky year in 2011, the Global Fund to Fight AIDS, Tuberculosis and Malaria is 'not in crisis,'" Inter Press Service reports, referring to comments made by the organization's deputy general manager, Debrework Zewdie, at a roundtable hosted by the Council on Foreign Relations on Wednesday. Zewdie noted the resumption of commitments to the fund from bilateral donors, despite the international economic crisis and last year's allegations of mismanagement, the news service adds.
Soligenix, Inc., a late-stage biopharmaceutical company, today announced that it has entered into a definitive license agreement with the University of Colorado (CU) for novel technology for use in the development of subunit vaccines with long-term stability, including stability at elevated temperatures.
Inovio Pharmaceuticals, Inc. today reported financial results for the quarter ended June 30, 2014. Total revenue was $3.8 million and $6.2 million for the three and six months ended June 30, 2014, compared to $786,000 and $2.2 million for the same periods in 2013.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Angela Maryann Pansera, DO 8926 Woodyard Rd, Ste 301, Clinton, MD 20735-4220 Ph: (301) 856-6718 | Dr Angela Maryann Pansera, DO 7801 Old Branch Ave, Ste 300, Clinton, MD 20735-1608 Ph: (301) 856-6718 |
News Archive
Patients with no schooling benefit least from blood thinning medications, reveals a European Heart Rhythm Association / European Society of Cardiology survey published today in Europace.
An open-source platform, OpenEP co-developed by researchers from the School of Biomedical Engineering & Imaging Sciences at King's College London has been made available to advance research on atrial fibrillation, a condition characterized by an irregular and often fast heartbeat.
"Although coming off a rocky year in 2011, the Global Fund to Fight AIDS, Tuberculosis and Malaria is 'not in crisis,'" Inter Press Service reports, referring to comments made by the organization's deputy general manager, Debrework Zewdie, at a roundtable hosted by the Council on Foreign Relations on Wednesday. Zewdie noted the resumption of commitments to the fund from bilateral donors, despite the international economic crisis and last year's allegations of mismanagement, the news service adds.
Soligenix, Inc., a late-stage biopharmaceutical company, today announced that it has entered into a definitive license agreement with the University of Colorado (CU) for novel technology for use in the development of subunit vaccines with long-term stability, including stability at elevated temperatures.
Inovio Pharmaceuticals, Inc. today reported financial results for the quarter ended June 30, 2014. Total revenue was $3.8 million and $6.2 million for the three and six months ended June 30, 2014, compared to $786,000 and $2.2 million for the same periods in 2013.
› Verified 1 days ago
Mrs. Insook Yoon, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 7503 Surratts Road, Clinton, MD 20735 Phone: 202-745-8000 Fax: 202-745-2269 | |
Dr. Robert J Hage, DO Radiology Medicare: Medicare Enrolled Practice Location: 7503 Surratts Road, Clinton, MD 20735 Phone: 410-764-0912 | |
Cecilia F Holden, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 8926 Woodyard Rd, Ste 301, Clinton, MD 20735 Phone: 301-856-3670 Fax: 301-868-0129 | |
Michael A Abramson, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 7503 Surratts Rd, Clinton, MD 20735 Phone: 301-868-8000 | |
Steven Lossef, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 7503 Surratts Road, Clinton, MD 20735 Phone: 202-884-5070 | |
Andrew Satinsky, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 7501 Surratts Rd. Suite 108, Southern Maryland Hospital Center, Clinton, MD 20735 Phone: 301-868-1100 |